Authors:
Savaskan, E
Olivieri, G
Brydon, L
Jockers, R
Krauchi, K
Wirz-Justice, A
Muller-Spahn, F
Citation: E. Savaskan et al., Cerebrovascular melatonin MT1-receptor alterations in patients with Alzheimer's disease, NEUROSCI L, 308(1), 2001, pp. 9-12
Authors:
Brydon, L
Petit, L
Delagrange, P
Strosberg, AD
Jockers, R
Citation: L. Brydon et al., Functional expression of MT2 (Mel1b) melatonin receptors in human PAZ6 adipocytes, ENDOCRINOL, 142(10), 2001, pp. 4264-4271
Authors:
Brydon, L
Roka, F
Petit, L
de Coppet, P
Tissot, M
Barrett, P
Morgan, PJ
Nanoff, C
Strosberg, AD
Jockers, R
Citation: L. Brydon et al., Dual signaling of human Mel1a melatonin receptors via G(i2), G(i3), and G(q/11) proteins, MOL ENDOCR, 13(12), 1999, pp. 2025-2038
Authors:
Roka, F
Brydon, L
Waldhoer, M
Strosberg, AD
Freissmuth, M
Jockers, R
Nanoff, C
Citation: F. Roka et al., Tight association of the human Mel(1a)-melatonin receptor and G(i): Precoupling and constitutive activity, MOLEC PHARM, 56(5), 1999, pp. 1014-1024
Authors:
Jockers, R
Angers, S
Da Silva, A
Benaroch, P
Strosberg, AD
Bouvier, M
Marullo, S
Citation: R. Jockers et al., beta(2)-adrenergic receptor down-regulation - Evidence for a pathway that does not require endocytosis, J BIOL CHEM, 274(41), 1999, pp. 28900-28908
Authors:
Petit, L
Lacroix, I
de Coppet, P
Strosberg, AD
Jockers, R
Citation: L. Petit et al., Differential signaling of human Mel1a and Mel1b melatonin receptors through the cyclic guanosine 3 '-5 '-monophosphate pathway, BIOCH PHARM, 58(4), 1999, pp. 633-639